CAI Q4 2019 Earnings — Caris Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

CAICaris Life Sciences, Inc.

$5B

Q4 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$100M-13.3% YoY

Gross Profit

$48M47.5% margin

Operating Income

$28M28.1% margin

Net Income

$8M7.8% margin

EPS (Diluted)

$0.45

QoQ Revenue Growth

-6.9%

Cash Flow

Operating Cash Flow

$66M

Free Cash Flow

$5M

Stock-Based Comp.

$616,000

Balance Sheet

Total Assets

$2.9B

Total Liabilities

$2.2B

Stockholders' Equity

$693M

Cash & Equivalents

$46M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$100M	$116M	-13.3%
Gross Profit	$48M	$57M	-16.7%
Operating Income	$28M	$39M	-27.5%
Net Income	$8M	$19M	-59.6%